Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV.
about
Therapeutic Potential of Spirooxindoles as Antiviral AgentsPatient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.Inflammatory biomarker changes and their correlation with Framingham cardiovascular risk and lipid changes in antiretroviral-naive HIV-infected patients treated for 144 weeks with abacavir/lamivudine/atazanavir with or without ritonavir in ARIES.Drug transporter pharmacogenetics in nucleoside-based therapies.A model-based approach for the evaluation of once daily dosing of lamivudine in HIV-infected children.
P2860
Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Abacavir/lamivudine fixed-dose ...... rapy for the treatment of HIV.
@ast
Abacavir/lamivudine fixed-dose ...... rapy for the treatment of HIV.
@en
type
label
Abacavir/lamivudine fixed-dose ...... rapy for the treatment of HIV.
@ast
Abacavir/lamivudine fixed-dose ...... rapy for the treatment of HIV.
@en
prefLabel
Abacavir/lamivudine fixed-dose ...... rapy for the treatment of HIV.
@ast
Abacavir/lamivudine fixed-dose ...... rapy for the treatment of HIV.
@en
P2860
P50
P1433
P1476
Abacavir/lamivudine fixed-dose ...... erapy for the treatment of HIV
@en
P2093
Kimberly K Scarsi
P2860
P2888
P356
10.1007/S12325-010-0006-9
P407
P577
2010-01-01T00:00:00Z